Dr. Moshe Neuman, founder & CEO of B.R.D, was selected as a regulatory consultant to the SPARK Project of Stanford University, global network extension in Israel at the Tel-Aviv University. http://spark-telaviv.tau.ac.il/
SPARK Program at the Tel-Aviv University, Isreal
You may also be interested in ...
Valuable resources presented at the 5th Annual Israeli National Clinical Trial Congress chaired by Dr. Neuman B.R.D CEO
In front of a large crowd of audiences, and in the presence and participation of… Read more >>
B.R.D presents it’s CRO Services at BioMed 2015 Conference
B.R.D CRO team is happy to take part at the BioMed 2015 exibition (Boot 192).… Read more >>
B.R.D shared its experience in conducting stem cell trials in ALS patients in Israel at initiation of Brainstorm trial in the United States.
Dr. Neuman, CEO of BRD, was asked to attend the investigator’s meeting at Mass General… Read more >>
All articles loaded
No more articles to load